Skip to main content
Clinical Trials/ISRCTN34155374
ISRCTN34155374Active, not recruitingUnknown

Short and long-term effect of a dietary supplement on UV protection and dark spots in healthy adults: a randomized, double-blind, placebo-controlled, parallel, clinical trial

Activ'inside0 sites66 target enrollmentStarted: April 8, 2024Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Active, not recruiting
Enrollment
66

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Healthy female (80%) and male (20%)
  • 2. Caucasian ethnicity
  • 3. Phototypes from I to III
  • 4. Age between 28 and 52 years inclusive
  • 5. Subject showing skin spots related to age, sun exposure or post-inflammatory hyperpigmentation, with at least one spot with a minimum diameter of 3 mm
  • 6. Willingness to not consume during the study period products other than the test product as judged by the investigator,
  • 7. Subjects registered with the National Health Service (NHS)
  • 8. Subjects certifying the truthfulness of the personal data disclosed to the investigator
  • 9. Subjects able to understand the language used in the investigation centre and the information given by the investigator
  • 10. Subjects able to respect the instructions given by the investigator as well as able to respect the study constraints and specific requirements
  • 11. The pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) should be stable for at least one month without any changes expected or planned during the study
  • 12. Commitment not to change the daily routine or the lifestyle
  • 13. Subjects who have not been recently involved in any other similar study (at least one month of wash-out)
  • 14. Subject under effective contraception (oral/not oral) therapy
  • 15. Subjects who accept not to be exposed in an intensive way to UV rays during the whole study duration
  • 16. Subject is aware of the study procedures and has signed an informed consent form and privacy information form.

Exclusion Criteria

  • 1. Subject does not meet the inclusion criteria
  • 2. Subjects participating or planning to participate in other clinical trials
  • 3. Subjects deprived of freedom by administrative or legal decision or under guardianship
  • 4. Subjects not able to be contacted in case of emergency
  • 5. Subjects admitted to a health or social facility
  • 6. Subjects planning a hospitalisation during the study
  • 7. Subjects who participated in a similar study without respecting an adequate washout period
  • 8. Subjects having an acute, chronic or progressive illness liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements
  • 9. Subjects under pharmacological treatments that are considered incompatible with the study requirement by the investigator
  • 10. Subjects having a skin disease or condition liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements
  • 11. Subject with known or suspected sensitization to one or more test formulation ingredients
  • 12. Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (for the women of childbearing potential)
  • 13. Consumption of food supplement(s) and/or use of topical skincare products that have an influence on skin response to UV rays or dark spots (currently or within the past 4 weeks before the study)
  • 14. Subjects accustomed to use tanning beds
  • 15. Subjects taking medication with photosensitizing potential, drugs and/or dietary supplements able to induce skin coloring, corticoids, currently or during the month before the study

Investigators

Similar Trials